Delafloxacin is a fluoroquinolone antibiotic used as an active pharmaceutical ingredient in pharmaceutical manufacturing. It was approved in June 2017 under the trade name Baxdela.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 189279-58-1
Delafloxacin meglumine
pharmaceutical raw material
Risperidone N-Oxide
pharmaceutical raw material
Magnesium aspartate
pharmaceutical raw material
Bremelanotide
pharmaceutical raw material
Firocoxib
pharmaceutical raw material
Ethyl 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-(isobutyryloxy)azetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate
pharmaceutical intermediate
Ethyl 1-(6-amino-3,5-difluoropyridin-2-yl)-6-fluoro-7-(3-(isobutyryloxy)azetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate
pharmaceutical intermediate
1-(6-amino-3,5-difluoro-2-pyridinyl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxoquinoline-3-carboxylic acid
DYDCPNMLZGFQTM-UHFFFAOYSA-N
C1C(CN1C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4=C(C=C(C(=N4)N)F)F)F)O